PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Fox, Keith A. A.
TI  - ROCKET-AF: Rivaroxaban vs Warfarin in Patients with Moderate Renal Insufficiency
DP  - 2011 Nov 01
TA  - MD Conference Express
PG  - 25--26
VI  - 11
IP  - 10
4099  - http://mdc.sagepub.com/content/11/10/25.short
4100  - http://mdc.sagepub.com/content/11/10/25.full
AB  - Patients with atrial fibrillation and moderate renal dysfunction have a higher risk of stroke and bleeding than patients with normal renal function, but respond favorably to reduced-dose rivaroxaban compared with warfarin, according to new findings from the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibitor Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation [ROCKET-AF; NCT00403767].